recently study published cast doubt efficacy sertraline zoloft ptsd finding drug better placebo kicker patent expired zoloft data flowing freely i make case data buried would longer hurt sales meaningful extent point data published least partially public relations move show honest companies sharing positive negative results psychiatric community research latest study appears may journal clinical psychiatry showed benefit drug week period placebo tended outperform zoloft majority outcome measures though differences small statistically insignificant degree patients significantly likely drop treatment zoloft unclear serious adverse events suicide attempts notable aggression etc article mention patients started study may september original draft study received journal march nearly years passed study completion writing data publication two prior studies found positive results found positive results zoloft published quickly negative results languished zoloft patent expired one earlier positive study list dates study occurred seems clear rushed publication much quicker negative study another positive study conducted may june published quite obvious positive studies rushed press negative study languished keep mind magnitude positive effect zoloft placebo even positive studies small moderate even positive news antidepressants treating ptsd show modest improvement relative placebo one tread cautiously change heart drug companies criticized widely failing disclose clinical trial data effort shore support medical community public large could possibly make sense publishing negative trial results gee look honest share good news bad news course positive results published quickly possible negative results published year delay well negative results pose threat corporate profits i impressed newfound dedication transparency note journalist kind story would merit broad audience plot pretty simple follow reeks corporate malfeasance subject new pfizer former cash cow antidepressant